Latest Business News
Sun Pharma to consider ₹15,000 crore NCD issue; board meeting on 12 October | Stock Market News
Sun Pharmaceutical Industries said in a regulatory filing…
The real test is not whether you avoid this failure, because you won’t. It’s whether you let it harden or shame you into inaction, or whether you learn from it; whether you choose to persevere.
Sun Pharmaceutical Industries said in a regulatory filing…